Paras Healthcare IPO 2025: Date, Price, GMP, Review, Allotment Details
The Paras Healthcare IPO, a mainboard IPO from Paras Healthcare Limited, is poised to raise significant funds to fuel its expansion in India’s growing healthcare sector. As the fifth-largest healthcare provider by bed capacity in North India, Bihar, and Jharkhand, the company has filed its DRHP with SEBI to raise approximately ₹[.] crores through a fresh issue and offer for sale (OFS). This article provides a comprehensive overview of the Paras Healthcare IPO, including tentative dates, price band, grey market premium (GMP), allotment details, financial performance, and expert review to guide investors.
Join Telegram
Join WhatsApp
Paras Healthcare IPO Details
The Paras Healthcare IPO is a book-built issue comprising a fresh issue of ₹400 crores and an OFS of up to 1.49 crore equity shares, each with a face value of ₹1. Below are the key details based on the DRHP and recent updates:
| Particulars | Details |
|---|---|
| IPO Opening Date | To be announced (2025) |
| IPO Closing Date | To be announced (2025) |
| Allotment Date | To be announced (2025) |
| Listing Date | To be announced (2025) |
| Face Value | ₹1 per share |
| Price Band | ₹[.] to ₹[.] per share |
| Lot Size | To be announced |
| Issue Size | ₹[.] crores |
| Fresh Issue | ₹400 crores |
| Offer for Sale | 1.49 crore shares |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Book Running Lead Managers | ICICI Securities, IIFL Capital Services, Motilal Oswal Investment Advisors |
| Registrar | Link Intime India Private Limited |
The IPO allocates 75% to Qualified Institutional Buyers (QIBs), 15% to High Net-Worth Individuals (HNIs), and 10% to retail investors. The minimum investment for retail investors will be announced once the lot size is finalized.
Paras Healthcare IPO Subscription Status
The subscription status for the Paras Healthcare IPO will be updated daily during the subscription period once the IPO opens in 2025. Investors can track live subscription data on the BSE, NSE, or the registrar’s portal (Link Intime India).
| Category | Subscription (Times) |
|---|---|
| QIB | To be updated |
| NII (HNI) | To be updated |
| Retail | To be updated |
| Total | To be updated |
Note: Subscription data will be available after the IPO opens in 2025.
Paras Healthcare IPO Allotment Status
The allotment for the Paras Healthcare IPO is expected to be finalized in 2025, following the close of the subscription period. Investors can check their allotment status on the registrar’s website (Link Intime India) or the BSE/NSE websites using their application number, PAN, or DP Client ID. Shares will be credited to demat accounts, and refunds will be processed for non-allotted applications.
Steps to Check Allotment Status:
- Visit the Link Intime India website (https://linkintime.co.in/Initial_Offer/public-issues.html).
- Select “Paras Healthcare IPO” from the dropdown menu.
- Enter your Application Number, PAN, or DP Client ID.
- Click “Search” to view your allotment status.
Note: Allotment status will be available after finalization in 2025.
Paras Healthcare IPO Grey Market Premium (GMP) Today
The Grey Market Premium (GMP) indicates the premium at which IPO shares trade in the unofficial market before listing. As of July 16, 2025, the GMP for the Paras Healthcare IPO is not available, as grey market activity has not yet started. Investors should monitor updates closer to the IPO opening for GMP trends.
| Date | GMP (₹) | Estimated Listing Price (₹) |
|---|---|---|
| July 16, 2025 | Not Available | Not Available |
| July 15, 2025 | Not Available | Not Available |
| July 14, 2025 | Not Available | Not Available |
| July 13, 2025 | Not Available | Not Available |
Disclaimer: GMP is unofficial and volatile. Base investment decisions on company fundamentals, not just GMP.
Paras Healthcare IPO Kostak Rates Today
The Kostak rate is the premium an investor earns by selling their IPO application in the grey market before allotment. As of July 16, 2025, the Kostak rate for the Paras Healthcare IPO is not available due to the absence of grey market activity. Check with grey market dealers for updates closer to the IPO opening.
| Date | Kostak Rate (₹) |
|---|---|
| July 16, 2025 | Not Available |
Paras Healthcare IPO Subject to Sauda Rates
The Subject to Sauda rate is the amount agreed for an IPO application, payable only if allotted. As of July 16, 2025, the Subject to Sauda rate for the Paras Healthcare IPO is not available, as grey market trading has not commenced.
| Date | Subject to Sauda (₹) |
|---|---|
| July 16, 2025 | Not Available |
Note: Kostak and Subject to Sauda rates are unofficial and may fluctuate as grey market activity begins.
About Paras Healthcare Limited
Incorporated in 1987 as Arbian Frozen Foods Private Limited, Paras Healthcare Limited transitioned to a public company in July 2024, adopting its current name. Headquartered in Gurugram, it is the fifth-largest healthcare provider by bed capacity in North India, Bihar, and Jharkhand, with 2,135 beds across eight hospitals as of March 31, 2024. Operating under the “Paras Health” brand, its hospitals are located in Gurugram and Panchkula (Haryana), Patna and Darbhanga (Bihar), Kanpur (Uttar Pradesh), Udaipur (Rajasthan), Ranchi (Jharkhand), and Srinagar (Jammu and Kashmir). The company focuses on specialized tertiary care in Tier 2 and 3 cities, offering services in cardiac sciences, oncology, neurosciences, gastroenterology, and orthopedics. With an asset-light model, Paras Healthcare plans to expand to 2,935 beds by 2029 through new hospitals in Gurugram and Ludhiana. It also invests in digital healthcare solutions to enhance patient access and operational efficiency. The company is promoted by Dr. Dharminder Kumar Nagar.
Paras Healthcare IPO Objectives
The net proceeds from the fresh issue will be used for:
- Investment in subsidiaries Paras Healthcare (Ranchi) Private Limited and Plus Medicare Hospitals Private Limited for repayment/prepayment of borrowings.
- General corporate purposes.
Paras Healthcare Financials
Paras Healthcare has shown revenue growth but remains loss-making. Below is a summary of its financial performance:
| Particulars | FY24 (₹ Crores) | FY23 (₹ Crores) | Growth (%) |
|---|---|---|---|
| Revenue | 1,151.02 | 936.05 | 22.96% |
| EBITDA | Not Available | Not Available | Not Available |
| PAT | (15.33) | (42.79) | 64.15% (Loss Reduction) |
The company’s focus on Tier 2 and 3 cities and its asset-light model support revenue growth, but profitability challenges persist.
Paras Healthcare IPO Strengths
- Market Position: Fifth-largest healthcare provider by bed capacity in North India, Bihar, and Jharkhand with 2,135 beds.
- First-Mover Advantage: Strong presence in underserved Tier 2 and 3 cities, enhancing patient access.
- Asset-Light Model: Efficient operations with lower capital intensity, supporting scalability.
- Clinical Expertise: Attracts renowned clinicians, ensuring high-quality care in specialties like oncology and cardiac sciences.
- Expansion Plans: Aims to increase bed capacity to 2,935 by 2029, with new hospitals in Gurugram and Ludhiana.
Paras Healthcare IPO Risks
- Loss-Making: Reported a ₹15.33 crore loss in FY24, indicating profitability challenges.
- Regional Dependency: Heavy reliance on North India, Bihar, and Jharkhand limits geographic diversification.
- High Competition: Faces competition from other healthcare providers in key markets.
- Talent Retention: Ongoing challenge to retain top clinicians.
- Regulatory Hurdles: Complex healthcare regulations may impact operations.
Paras Healthcare IPO Review
The Paras Healthcare IPO offers exposure to India’s growing healthcare sector, particularly in underserved Tier 2 and 3 cities. The company’s 22.96% revenue growth from FY23 to FY24 and a 64.15% reduction in losses reflect operational improvements and market potential. Its asset-light model, first-mover advantage in key regions, and plans to expand to 2,935 beds by 2029 are key strengths. However, persistent losses (₹15.33 crores in FY24), regional concentration, and competitive pressures pose risks. The absence of GMP and price band data limits visibility on listing gains. X posts highlight investor interest in healthcare IPOs, but profitability concerns may temper enthusiasm. Long-term investors with high risk tolerance may find this IPO attractive, but short-term investors should be cautious due to financial and regulatory risks.
Recommendation: Consider for long-term investment due to growth potential, but consult a financial advisor given the company’s losses.
How to Apply for Paras Healthcare IPO
Investors can apply through ASBA (Applications Supported by Blocked Amount) or UPI via their bank or brokers like Zerodha, Bajaj Broking, or Kotak Securities.
Steps to Apply:
- Log in to your demat account or broker’s platform.
- Navigate to the IPO section and select “Paras Healthcare IPO.”
- Enter the number of lots and price (to be announced).
- Provide your UPI ID or bank details for payment.
- Submit the application and approve the UPI mandate.
Check your broker’s IPO application process for detailed instructions.
Paras Healthcare IPO FAQs
When does the Paras Healthcare IPO open and close?
The IPO dates are yet to be announced for 2025.
What is the price band of the Paras Healthcare IPO?
The price band is not yet announced.
What is the minimum investment for retail investors?
The minimum investment will be announced once the lot size is finalized.
How can I check the Paras Healthcare IPO allotment status?
Visit the Link Intime India website (https://linkintime.co.in/Initial_Offer/public-issues.html), select “Paras Healthcare IPO,” and enter your PAN, application number, or DP Client ID.
What is the GMP of the Paras Healthcare IPO today?
As of July 16, 2025, the GMP is not available, as grey market activity has not started.
Where will the Paras Healthcare IPO be listed?
The IPO will be listed on the BSE and NSE, with the listing date to be announced in 2025.
Also Read: Vikram Solar IPO 2025: Date, Price, GMP, Review, Allotment Details
